Kezar Life Sciences, Inc. (KZR)

Import this data to Google Sheets with:

=jivedata("KZR","financials")

Full statements spill as a table. For one cell: =jivedata("KZR","Revenue") or =jivedata("KZR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Kezar Life Sciences, Inc.

KZR • CIK 0001645666

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$7,000	$0	$0	$0
Operating Income (Loss)	$-111,424	$-90,605	$-59,107	$-48,843
Investment Income, Interest	—	$8,462	$4,444	$3,633
Other Expenses	—	—	$1,370	$1,370
Net Income (Loss) Attributable to Parent	$-101,870	$-83,736	$-56,033	$-45,233
Weighted Average Number of Shares Outstanding, Basic	72,553,645	7,290,245	7,316,890	7,355,141
Research and Development Expense	$85,697	$65,742	$33,756	$23,121
General and Administrative Expense	$26,540	$23,393	$18,514	$18,273
Restructuring Costs and Asset Impairment Charges	$6,187	$1,470	$6,837	$7,449
Operating Expenses	$118,424	$90,605	$59,107	$48,843

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$35,493	$41,749	$71,878	$66,229
Marketable Securities, Current	$165,879	$90,496	$0	$0
Property, Plant and Equipment, Net	$3,912	$2,893	$166	$0
Prepaid Expense and Other Assets, Current	$5,578	$5,243	$3,334	$1,334
Operating Lease, Right-of-Use Asset	$4,778	$1,886	$749	$436
Assets Held-for-sale, Not Part of Disposal Group, Current	—	—	$520	$0
Other Assets, Noncurrent	$5,595	$2,415	$0	$0
Assets, Current	$206,950	$137,488	$75,732	$67,563
Assets	$221,235	$144,682	$76,647	$67,999
Operating Lease, Liability, Noncurrent	$5,852	$2,326	$0	$0
Long-term Debt, Excluding Current Maturities	$10,069	$5,111	$0	$0
Liabilities	$33,665	$27,766	$6,574	$2,762
Accounts Payable, Current	$8,251	$3,651	$507	$273
Accrued Liabilities, Current	$6,481	$7,935	$3,741	$1,135
Operating Lease, Liability, Current	$3,012	$3,526	$2,326	$1,354
Debt, Current	—	$5,217	$0	$0
Liabilities, Current	$17,744	$20,329	$6,574	$2,762
Common Stock, Value, Issued	$73	$7	$7	$7
Preferred Stock, Value, Issued	$0	$0	$0	$0
Additional Paid in Capital, Common Stock	$538,390	$551,570	$560,598	$561,518
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-130	$-162	$0	$0
Retained Earnings (Accumulated Deficit)	$-350,763	$-434,499	$-490,532	$-496,288
Stockholders' Equity Attributable to Parent	$187,570	$116,916	$70,073	$65,237
Common Stock, Shares Authorized	250,000,000	250,000,000	250,000,000	250,000,000
Common Stock, Shares, Issued	72,779,077	7,303,629	7,331,739	7,374,375
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0	0	0
Unbilled Receivables, Current	—	—	$1,741	$0
Prepaid Insurance	$712	$574	$463	$226
Interest Receivable, Current	—	$424	$184	$206
Other Prepaid Expense, Current	$251	$351	$200	$190
Property, Plant and Equipment, Gross	$9,332	$9,338	$3,452	$0
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$5,420	$6,445	$3,286	$0
Depreciation	$1,100	$1,000	$900	$47
Impairment of Long-Lived Assets to be Disposed of	$208	$0	$907	$907
Employee-related Liabilities, Current	$3,708	$2,716	$66	$0
Accrued Professional Fees, Current	$110	$111	$42	$850
Other Accrued Liabilities, Current	$106	$55	$298	$77

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-101,870	$-83,736	$-56,033	$-45,233
Net Cash Provided by (Used in) Operating Activities	$-81,645	$-74,212	$-51,777	$-42,032
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$-2	$-63	$28	$23
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-4,963	$6,256	$30,129	$29,227
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$35,493	$41,749	$71,878	$101,105
Depreciation, Depletion and Amortization	$1,066	$1,040	$897	$693
Payments to Acquire Property, Plant, and Equipment	$1,810	$29	$8	$0
Share-based Payment Arrangement, Noncash Expense	$18,137	$13,011	$8,963	$6,837
Payments to Acquire Marketable Securities	$180,399	$91,337	$42,631	$42,631
Accretion (Amortization) of Discounts and Premiums, Investments	$6,830	$5,043	$2,002	$1,314
Proceeds from Sale and Maturity of Marketable Securities	$258,250	$171,794	$134,981	$121,231
Amortization of Debt Issuance Costs and Discounts	$235	$259	$176	$17
Proceeds from Sale of Property, Plant, and Equipment	$5	$0	$121	$650
Gain (Loss) on Extinguishment of Debt	—	—	$-146	$-146
Net Cash Provided by (Used in) Investing Activities	$76,046	$80,428	$92,463	$80,250
Impairment of Long-Lived Assets to be Disposed of	$208	$0	$907	$907
Operating Lease, Impairment Loss	$2,700	$1,549	$0	$0
Gain (Loss) on Disposition of Property Plant Equipment	$-3	$-8	$-290	$-290
Repayments of Long-term Debt	—	—	$10,650	$9,346
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised	$638	$103	$65	$332
Net Cash Provided by (Used in) Financing Activities	$638	$103	$-10,585	$-9,014
Interest Paid, Excluding Capitalized Interest, Operating Activities	$1,315	$1,335	$766	$577
Increase (Decrease) in Prepaid Expense and Other Assets	$-3,583	$-335	$-1,909	$-4,623
Increase (Decrease) in Other Operating Assets	$4,921	$-3,180	$-2,415	$-674
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$6,347	$-3,146	$-7,338	$-6,581

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("KZR","financials")

Full statements spill as a table. For one cell: =jivedata("KZR","Revenue") or =jivedata("KZR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.